Copolov D - Search Results

1

Studies on serotonergic markers in the human hippocampus: changes in subjects with bipolar disorder.

Dean B, Scarr E, Pavey G, Copolov D. Dean B, et al. Among authors: copolov d. J Affect Disord. 2003 Jun;75(1):65-9. doi: 10.1016/s0165-0327(02)00021-6. J Affect Disord. 2003. PMID: 12781352

2

High-resolution phosphor imaging: validation for use with human brain tissue sections to determine the affinity and density of radioligand binding.

Pavey GM, Copolov DL, Dean B. Pavey GM, et al. J Neurosci Methods. 2002 May 15;116(2):157-63. doi: 10.1016/s0165-0270(02)00036-5. J Neurosci Methods. 2002. PMID: 12044665

3

Cannabis-sensitive dopaminergic markers in postmortem central nervous system: changes in schizophrenia.

Dean B, Bradbury R, Copolov DL. Dean B, et al. Biol Psychiatry. 2003 Apr 1;53(7):585-92. doi: 10.1016/s0006-3223(02)01545-7. Biol Psychiatry. 2003. PMID: 12679236

4

Hippocampal 5-hydroxytryptamine receptors: abnormalities in postmortem brain from schizophrenic subjects.

Scarr E, Pavey G, Copolov D, Dean B. Scarr E, et al. Among authors: copolov d. Schizophr Res. 2004 Dec 1;71(2-3):383-92. doi: 10.1016/j.schres.2004.02.007. Schizophr Res. 2004. PMID: 15474910

5

[3H]paroxetine binding is altered in the hippocampus but not the frontal cortex or caudate nucleus from subjects with schizophrenia.

Dean B, Opeskin K, Pavey G, Naylor L, Hill C, Keks N, Copolov DL. Dean B, et al. Among authors: copolov dl. J Neurochem. 1995 Mar;64(3):1197-202. doi: 10.1046/j.1471-4159.1995.64031197.x. J Neurochem. 1995. PMID: 7861151

6

Serotonin2 receptors and the serotonin transporter in the schizophrenic brain.

Dean B, Hayes W, Opeskin K, Naylor L, Pavey G, Hill C, Keks N, Copolov DL. Dean B, et al. Among authors: copolov dl. Behav Brain Res. 1996;73(1-2):169-75. doi: 10.1016/0166-4328(96)00091-5. Behav Brain Res. 1996. PMID: 8788497

7

A proposed pathological model in the hippocampus of subjects with schizophrenia.

Scarr E, Copolov DL, Dean B. Scarr E, et al. Among authors: copolov dl. Clin Exp Pharmacol Physiol. 2001 Jan-Feb;28(1-2):70-3. doi: 10.1046/j.1440-1681.2001.03400.x. Clin Exp Pharmacol Physiol. 2001. PMID: 11153541

8

Changes in the serotonin transporter in the hippocampus of subjects with schizophrenia identified using [3H]paroxetine.

Naylor L, Dean B, Opeskin K, Pavey G, Hill C, Keks N, Copolov D. Naylor L, et al. Among authors: copolov d. J Neural Transm (Vienna). 1996;103(6):749-57. doi: 10.1007/BF01271234. J Neural Transm (Vienna). 1996. PMID: 8836936

9

A change in the density of [(3)H]flumazenil, but not [(3)H]muscimol binding, in Brodmann's Area 9 from subjects with bipolar disorder.

Dean B, Pavey G, McLeod M, Opeskin K, Keks N, Copolov D. Dean B, et al. Among authors: copolov d. J Affect Disord. 2001 Oct;66(2-3):147-58. doi: 10.1016/s0165-0327(00)00294-9. J Affect Disord. 2001. PMID: 11578667

10

The heterogeneity of central benzodiazepine receptor subtypes in the human hippocampal formation, frontal cortex and cerebellum using [3H]flumazenil and zolpidem.

McLeod M, Pralong D, Copolov D, Dean B. McLeod M, et al. Among authors: copolov d. Brain Res Mol Brain Res. 2002 Aug 15;104(2):203-9. doi: 10.1016/s0169-328x(02)00381-9. Brain Res Mol Brain Res. 2002. PMID: 12225875

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

217 results

Search Page

Filters